Comprehensive Metabolic Panel (CMP) Testing Market, By Analytes, By Disease, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

Description

REPORT HIGHLIGHT

Comprehensive Metabolic Panel (CMP) Testing Market size was valued at USD 12,645 Million in 2024, expanding at a CAGR of 9.4% from 2024 to 2032.

A Comprehensive Metabolic Panel (CMP) is a blood test that measures 14 different substances in the blood to provide information about the body's chemical balance and metabolism. It helps evaluate organ function, especially the liver and kidneys, and monitors conditions such as diabetes, liver disease, and electrolyte imbalances. The CMP includes tests for glucose, calcium, electrolytes (sodium, potassium, carbon dioxide, chloride), kidney function markers (BUN, creatinine), and liver enzymes (ALP, ALT, AST, bilirubin, albumin, total protein). Often part of routine health checkups, it aids in early detection and ongoing monitoring of various health conditions to support timely medical intervention.

Comprehensive Metabolic Panel (CMP) Testing Market- Market Dynamics

Growing Demand for Preventive Healthcare

The rising emphasis on preventive healthcare is a major driver of the Comprehensive Metabolic Panel (CMP) testing market. With increasing awareness about early diagnosis and disease management, both patients and healthcare providers are prioritizing routine health checkups. CMP tests, which offer a broad overview of organ function and metabolic health, are becoming essential tools for identifying potential health issues before symptoms appear. Additionally, the growing prevalence of chronic conditions such as diabetes, kidney disease, and liver disorders is further fueling demand. Government initiatives and insurance coverage for preventive screenings are also contributing to the market's expansion.

Comprehensive Metabolic Panel (CMP) Testing Market- Key Insights

According to our research analyst, the global Comprehensive Metabolic Panel (CMP) Testing Market is expected to develop at a CAGR of approximately 9.4% between 2024-2032.

Segmented by Analytes in 2024, the Glucose category dominated the market.

Based on Disease, the Diabetes segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

Comprehensive Metabolic Panel (CMP) Testing Market- Segmentation Analysis:

The global Comprehensive Metabolic Panel (CMP) Testing Market is divided into Four categories: Analytes, Disease, End-use, and Region.

By analytes, the Comprehensive Metabolic Panel (CMP) testing market is segmented into potassium (K+), sodium (Na+), chloride (Cl-), carbon dioxide (CO2), glucose, blood urea nitrogen (BUN), creatinine, calcium (Ca2+), albumin, total protein, alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin. Among these, glucose testing dominates the market due to the global rise in diabetes and prediabetes cases. Early detection of abnormal blood sugar levels is critical in managing metabolic disorders and preventing complications. As a result, glucose analysis is commonly included in both routine checkups and disease-specific screenings. The increasing demand for point-of-care testing and home-based monitoring also contributes to the higher frequency and accessibility of glucose testing, further strengthening its market leadership within CMP analytes.

By disease, the Comprehensive Metabolic Panel (CMP) testing market is segmented into kidney diseases, liver diseases, diabetes, and others. Among these, diabetes is the dominant segment, primarily due to its widespread prevalence and the growing global health burden associated with the condition. CMP tests play a critical role in diagnosing and monitoring diabetes by evaluating blood glucose levels and assessing organ functions affected by the disease, such as the kidneys and liver. The increasing incidence of type 2 diabetes, driven by sedentary lifestyles, poor dietary habits, and aging populations, has heightened the need for routine metabolic assessments. Moreover, awareness campaigns and government healthcare programs promoting early detection and preventive care have further propelled the demand for CMP testing in diabetes management.

Comprehensive Metabolic Panel (CMP) Testing Market- Geographical Insights

Geographically, the Comprehensive Metabolic Panel (CMP) Testing Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America dominates the Comprehensive Metabolic Panel (CMP) testing market due to its advanced healthcare infrastructure, high healthcare spending, and widespread adoption of preventive care practices. The United States, in particular, contributes significantly with a high prevalence of chronic conditions such as diabetes, kidney disorders, and liver diseases. Regular health screening and strong insurance coverage further drive the demand for CMP tests. Additionally, the presence of leading diagnostic laboratories and increased public awareness about early disease detection play crucial roles. Strategic initiatives by healthcare providers and favorable government policies reinforce North America's leadership in the global CMP testing market.

Asia Pacific is emerging as a key growth region in the CMP testing market, driven by the rising incidence of chronic diseases and increasing healthcare awareness. Countries like China, India, and Japan are experiencing a surge in demand for diagnostic testing due to rapid urbanization, changing lifestyles, and expanding middle-class populations. Governments in the region are investing in healthcare infrastructure and promoting preventive health programs, which support market growth. Furthermore, the affordability and accessibility of diagnostic services are improving through both public and private healthcare expansions. These factors collectively position Asia Pacific as one of the most promising markets for CMP testing.

Comprehensive Metabolic Panel (CMP) Testing Market- Competitive Landscape:

The CMP testing market is dominated by established diagnostic firms such as Abbott, Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), and Sonic Healthcare. These companies offer a broad range of metabolic and biochemical tests with high accuracy and reliability. Heavy investments in R&D and advanced diagnostic technologies help maintain regulatory compliance and product innovation. New entrants focus on integrating AI and point-of-care testing to enhance diagnostic speed and accessibility. This competitive environment drives continuous advancements in testing efficiency, accuracy, and convenience, supporting wider adoption of CMP testing in clinical and preventive healthcare settings globally.

Recent Developments:

In March 2024, Abbott launched a next-generation point-of-care blood analyzer designed for rapid metabolic panel testing, improving turnaround time and accessibility in remote healthcare settings.

In January 2025, Quest Diagnostics expanded its laboratory services by opening a state-of-the-art testing facility in Texas, boosting capacity for metabolic and genetic testing to meet rising demand.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott
Quest Diagnostics
Laboratory Corporation of America Holdings Limited
Sonic Healthcare
Unipath
SYNLAB International GmbH
ARUP Laboratories
Genoptix Inc.
Nova Medical
Others

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY ANALYTES - MARKET ANALYSIS, 2019 - 2032

K+
Na+
Cl-
CO2
Glucose
BUN
Creatinine
Ca++
Albumin
Total Protein
ALP
ALT
AST
Total Bilirubin

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY DISEASE - MARKET ANALYSIS, 2019 - 2032

Kidney Diseases
Liver Diseases
Diabetes
Others

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032

Laboratories
Emergency Departments
Hospital Wards
Primary Care
Pharmacy
Telemedicine
PoC
Emergency Departments
Hospital Wards
Primary Care
Pharmacy
Telemedicine
PoC (Instruments)
Piccolo Xpress
Skyla-HB1
DRI-CHEM NX500
Others

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5325

1. Comprehensive Metabolic Panel (CMP) Testing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Analytes
- 2.1.2. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Disease
- 2.1.3. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by End Use
- 2.1.4. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Country
- 2.1.5. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Region
2.2. Competitive Insights

3. Comprehensive Metabolic Panel (CMP) Testing Key Market Trends

3.1. Comprehensive Metabolic Panel (CMP) Testing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Comprehensive Metabolic Panel (CMP) Testing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Comprehensive Metabolic Panel (CMP) Testing Market Opportunities
3.4. Comprehensive Metabolic Panel (CMP) Testing Market Future Trends

4. Comprehensive Metabolic Panel (CMP) Testing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Comprehensive Metabolic Panel (CMP) Testing Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Comprehensive Metabolic Panel (CMP) Testing Market Landscape

6.1. Comprehensive Metabolic Panel (CMP) Testing Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Comprehensive Metabolic Panel (CMP) Testing Market - By Analytes

7.1. Overview
- 7.1.1. Segment Share Analysis, By Analytes, 2023 & 2032 (%)
- 7.1.2. K+
- 7.1.3. Na+
- 7.1.4. Cl-
- 7.1.5. CO2
- 7.1.6. Glucose
- 7.1.7. BUN
- 7.1.8. Creatinine
- 7.1.9. Ca++
- 7.1.10. Albumin
- 7.1.11. Total Protein
- 7.1.12. ALP
- 7.1.13. ALT
- 7.1.14. AST
- 7.1.15. Total Bilirubin

8. Comprehensive Metabolic Panel (CMP) Testing Market - By Disease

8.1. Overview
- 8.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
- 8.1.2. Kidney Diseases
- 8.1.3. Liver Diseases
- 8.1.4. Diabetes
- 8.1.5. Others

9. Comprehensive Metabolic Panel (CMP) Testing Market - By End Use

9.1. Overview
- 9.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
- 9.1.2. Laboratories
  - 9.1.2.1. Emergency Departments
  - 9.1.2.2. Hospital Wards
  - 9.1.2.3. Primary Care
  - 9.1.2.4. Pharmacy
  - 9.1.2.5. Telemedicine
- 9.1.3. PoC
  - 9.1.3.1. Emergency Departments
  - 9.1.3.2. Hospital Wards
  - 9.1.3.3. Primary Care
  - 9.1.3.4. Pharmacy
  - 9.1.3.5. Telemedicine
- 9.1.4. PoC (Instruments)
  - 9.1.4.1. Piccolo Xpress
  - 9.1.4.2. Skyla-HB1
  - 9.1.4.3. DRI-CHEM NX500
  - 9.1.4.4. Others

10. Comprehensive Metabolic Panel (CMP) Testing Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.3.8. France
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. France Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.3.8.4. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.8.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.3.9. Italy
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. Italy Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.3.9.4. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.9.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.3.10. Spain
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. United Kingdom Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.3.10.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.10.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.3.11. United Kingdom
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.3. United Kingdom Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.3.11.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.11.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.3.12. Russia
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Russia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.3.13. Netherlands
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Netherlands Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.3.14. Sweden
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Sweden Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.3.15. Poland
  - 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.2. Poland Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.3.15.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.3.16. Rest of Europe
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.16.3. Rest of the Europe Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.3.16.4. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.4.9. South Korea
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. South Korea Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.4.9.4. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.9.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.4.10. Japan
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. Japan Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.4.10.4. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.10.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Comprehensive Metabolic Panel (CMP) Testing Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Abbott
- 11.2.2. Quest Diagnostics
- 11.2.3. Laboratory Corporation of America Holdings Limited
- 11.2.4. Sonic Healthcare
- 11.2.5. Unipath
- 11.2.6. SYNLAB International GmbH
- 11.2.7. ARUP Laboratories
- 11.2.8. Genoptix Inc.
- 11.2.9. Nova Medical
- 11.2.10. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us